SVB Leerink reiterated coverage on Silverback Therapeutics with a new price target

5/17/21 6:19:07 AM ET

Specialty Chemicals

Consumer Discretionary

SVB Leerink reiterated coverage of Silverback Therapeutics with a rating of Outperform and set a new price target of $46.00 from $49.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SBTX

Date	Price Target	Rating	Analyst
4/4/2022	$25.00 → $3.50	Buy → Neutral	Goldman
4/1/2022	$25.00 → $1.80	Outperform → Mkt Perform	SVB Leerink
4/1/2022	$32.00 → $6.00	Buy → Hold	Stifel
4/1/2022		Buy → Neutral	H.C. Wainwright
11/12/2021	$42.00 → $25.00	Outperform	SVB Leerink
8/16/2021	$46.00 → $49.00	Outperform	SVB Leerink